Malesci
Malesci is an Italian company with over 165 years of experience in research, pharmaceutical production, and scientific information. Its mission is to promote health and improve people's quality of life, with expertise in Gastroenterology, Cardiology, and Pneumology. The company has a rich history of innovation, scientific research, and collaboration with healthcare professionals, and is part of the Menarini Group. It operates in various therapeutic areas including Allergological, Antibiotic, Cardiovascular, Pain, Gastroenterological, Respiratory, and Urological. Malesci is committed to ethics, transparency, and patient safety, with a focus on pharmacovigilance and ethical business practices.
Industries
Nr. of Employees
medium (51-250)
Malesci
Sede Legale: Bagno a Ripoli – Via Lungo l’Ema, 7– 50012 Bagno a Ripoli(Fi)
Products
Esomeprazole (proton pump inhibitor)
Proton pump inhibitor provided in multiple oral capsule and sachet strengths and an intravenous vial for treatment of acid-related disorders.
Olmesartan and fixed-dose combination antihypertensives
Angiotensin receptor antagonist therapies available as monotherapy and in fixed-dose combinations with calcium antagonists or diuretics for blood pressure control.
Clarithromycin (macrolide antibiotic)
Macrolide antibiotic available in multiple oral and paediatric formulations and injectable presentation for the treatment of bacterial infections.
Bilastine (second-generation antihistamine)
Non-sedating antihistamine offered in multiple oral formulations for treatment of allergic rhinitis and urticaria.
Theophylline (bronchodilator)
Oral theophylline tablets in multiple strengths used as bronchodilator therapy in respiratory medicine.
Balsalazide (intestinal anti-inflammatory agent)
Oral capsule formulation indicated for inflammatory bowel conditions such as ulcerative colitis.
Esomeprazole (proton pump inhibitor)
Proton pump inhibitor provided in multiple oral capsule and sachet strengths and an intravenous vial for treatment of acid-related disorders.
Olmesartan and fixed-dose combination antihypertensives
Angiotensin receptor antagonist therapies available as monotherapy and in fixed-dose combinations with calcium antagonists or diuretics for blood pressure control.
Clarithromycin (macrolide antibiotic)
Macrolide antibiotic available in multiple oral and paediatric formulations and injectable presentation for the treatment of bacterial infections.
Bilastine (second-generation antihistamine)
Non-sedating antihistamine offered in multiple oral formulations for treatment of allergic rhinitis and urticaria.
Theophylline (bronchodilator)
Oral theophylline tablets in multiple strengths used as bronchodilator therapy in respiratory medicine.
Balsalazide (intestinal anti-inflammatory agent)
Oral capsule formulation indicated for inflammatory bowel conditions such as ulcerative colitis.
Services
In-house monitoring and management of adverse event reports for marketed medicines, including intake, case processing, clinical review, database entry, signal detection and reporting aligned with regulatory authority requirements.
Organisation and sponsorship of clinical congresses, continuing medical education courses and production of editorial initiatives to disseminate clinical and therapeutic knowledge to healthcare professionals.
In-house monitoring and management of adverse event reports for marketed medicines, including intake, case processing, clinical review, database entry, signal detection and reporting aligned with regulatory authority requirements.
Organisation and sponsorship of clinical congresses, continuing medical education courses and production of editorial initiatives to disseminate clinical and therapeutic knowledge to healthcare professionals.
Expertise Areas
- Pharmacovigilance and drug safety
- Regulatory compliance and corporate governance
- Transparency reporting and data privacy compliance
- Drug formulation and pharmaceutical manufacturing
Key Technologies
- Post-marketing safety surveillance systems
- Pharmacovigilance database management
- Drug formulation and galenic preparation methods
- Fixed-dose combination formulation